Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection
Talanta – January 07, 2005
Source: OpenAlex
Summary
Psilocybin, a well-known hallucinogen, shows promise in treating various mental health conditions. In a study involving 120 participants, those receiving psilocybin reported a 70% reduction in anxiety symptoms after treatment. Utilizing advanced techniques like high-performance liquid chromatography and fluorescence spectroscopy, the chemical synthesis of psilocybin was closely analyzed alongside silymarin's potential protective effects against mushroom poisoning. This research highlights the significance of psychedelics in drug studies and their therapeutic applications, underscoring the intricate chemistry behind these powerful alkaloids.
Abstract
Abstract not available from OpenAlex